Canon to make Redlen Technologies a wholly owned subsidiary

Canon announced that it has reached an agreement with Redlen Technologies. (“Redlen”; Headquarters: British Columbia, Canada; President and CEO: Glenn Bindley) to conclude a share transfer agreement, making Redlen a wholly owned subsidiary of Canon.

In 2016, Phase V of Canon’s Excellent Global Plan, a series of rolling five-year initiatives, commenced under the policy of “achieving new growth through a grand strategic transformation” that included strengthening and expanding the medical business. In 2021, Phase VI commenced under the policy of “accelerating our corporate portfolio transformation by improving productivity and creating new businesses” and enhance competitiveness through company-wide realignment into a new industry-oriented business group structure. The Medical Group is one of those four new business groups.

Redlen possesses top-class technology for development and manufacture of Cadmium Zinc Telluride (CZT) semiconductor detector modules that are used in diagnostic imaging systems, security inspection systems and other devices. By using this technology in next-generation photon-counting CT systems (PCCT), it is expected to enable clearer imaging of specific substances in the body. This will allow early detection of very small lesions and subtle pathological changes, which has been difficult with conventional technologies. Furthermore, since PCCT systems can obtain images with less noise using weaker x-ray radiation than conventional CT, it is expected to reduce the physical burden on patients by significantly reducing exposure dose and improving diagnostic accuracy with higher-resolution imaging.

With the acquisition of Redlen, Canon will obtain advanced technology used in CZT semiconductor detector modules, which play an important role in the development of PCCT. This will enable Canon Medical Systems Corporation, a subsidiary of Canon, to accelerate the development of competitive PCCT systems to strengthen the medical systems business. In addition, Canon will provide CZT semiconductor detector modules to medical equipment manufacturers around the world, thus helping strengthen Canon’s medical component business. In this way, Canon will continue to contribute to the advancement of global diagnostic imaging.

Source: https://global.canon/

Related presentations

Cet article vous a plu ?

Partagez-le sur vos réseaux sociaux

Teardown_track_automotive